Compound Detail
CHEMBL39541
DOLASTATIN-10 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
Basic Information
| ChEMBL ID | CHEMBL39541 |
| Name | DOLASTATIN-10 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | OFDNQWIFNXBECV-VFSYNPLYSA-N |
17
Targets
31
Activities
2
Assay Types
0
PK Parameters
20
Publications
3
Known Names
9
Indications
1
Mechanisms
Molecular Properties
785.1
MW (Da)
5.19
ALogP
9
HBA
2
HBD
133.4
PSA (Ų)
0.18
QED
2
Ro5 Violations
21
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Unknown |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tubulin inhibitor | INHIBITOR | Tubulin | ✓ | ✓ |
Indications
Gallbladder Neoplasms Kidney Neoplasms Leukemia Lymphoma Ovarian Neoplasms Pancreatic Neoplasms Prostatic Neoplasms, Castration-Resistant Sarcoma Myelodysplastic Syndromes
Activity Summary
IC50 30 meas. best 10.74
EC50 1 meas. best 9.6
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HT-29 CHEMBL384 | IC50 | 10.74 | 10.35 | 0.0 | 4 |
| MCF7 CHEMBL387 | IC50 | 10.52 | 10.3 | 0.0 | 2 |
| L1210 CHEMBL386 | IC50 | 10.52 | 10.03 | 0.0 | 3 |
| NCI-H69 CHEMBL614805 | IC50 | 10.49 | 10.49 | 0.0 | 1 |
| NCI-H446 CHEMBL612440 | IC50 | 10.49 | 10.49 | 0.0 | 1 |
| NCI-H510A CHEMBL2366332 | IC50 | 10.49 | 10.49 | 0.0 | 1 |
| NCI-H82 CHEMBL2366077 | IC50 | 10.49 | 10.49 | 0.0 | 1 |
| KB CHEMBL398 | IC50 | 10.39 | 10.335 | 0.0 | 2 |
| LoVo CHEMBL614721 | IC50 | 10.18 | 10.15 | 0.1 | 2 |
| Plasmodium falciparum CHEMBL364 | IC50 | 10.0 | 10.0 | 0.1 | 1 |
| A10 CHEMBL614513 | EC50 | 9.6 | 9.6 | 0.2 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 9.32 | 8.0433 | 0.5 | 3 |
| Tubulin CHEMBL2095182 | IC50 | 9.3 | 7.9133 | 0.5 | 3 |
| CA46 CHEMBL612566 | IC50 | 7.52 | 7.52 | 30.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.16 | 6.04 | 700.0 | 2 |
| Tubulin alpha chain CHEMBL3658 | IC50 | 5.66 | 5.66 | 2200.0 | 1 |
| Tubulin CHEMBL2094134 | IC50 | 5.66 | 5.66 | 2200.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 27380142 | 10.1021/acs.jnatprod.6b00203 | NON-PROTEIN TARGET | 5 |
| 16124759 | 10.1021/np058033l | Unchecked | 3 |
| 35072477 | 10.1021/acs.jnatprod.1c01135 | NCI-H446 | 3 |
| 25635943 | 10.1021/np500931q | HT-29 | 2 |
| 35072477 | 10.1021/acs.jnatprod.1c01135 | Tubulin | 2 |
| 35072477 | 10.1021/acs.jnatprod.1c01135 | ADMET | 2 |
| 16124759 | 10.1021/np058033l | MCF7 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 11473421 | 10.1021/np010049y | KB | 2 |
| 11473421 | 10.1021/np010049y | LoVo | 2 |
| 11473421 | 10.1021/np010049y | A10 | 2 |
| 27380142 | 10.1021/acs.jnatprod.6b00203 | HCT-116 | 2 |
| 16837194 | 10.1016/j.bmcl.2006.06.071 | CA46 | 1 |
| 39068862 | 10.1016/j.ejmech.2024.116709 | HT-29 | 1 |
| 9554885 | 10.1021/jm970800t | Tubulin | 1 |
| 9554885 | 10.1021/jm970800t | L1210 | 1 |
| 9554885 | 10.1021/jm970800t | HT-29 | 1 |
| 9871690 | 10.1016/s0960-894x(98)00034-1 | P388 | 1 |
| 9873636 | 10.1016/s0960-894x(98)00511-3 | L1210 | 1 |
Data from ChEMBL 36 via Core Engine